mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-07 |
mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
-0.2 |
3e-07 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
5e-07 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
7e-07 |
mRNA |
KPT185 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-06 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-06 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-06 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-06 |
mRNA |
CI-976 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-06 |
mRNA |
AZD6482 |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
5e-06 |